Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-4297-31.
Published February 1, 2017 · Recall initiated: December 22, 2016
Summary
FDA records drug Class II recall D-0437-2017, published February 1, 2017 and initiated December 22, 2016. Recalling firm: Roxane Laboratories, Inc.; Status: Terminated; Reported quantity: 6493 bottles; Lot: Lot# 660833A, Exp 08/31/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.
What to do
Voluntary: Firm initiated · Letter
Get an email if FUROSEMIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FUROSEMIDE
- Manufacturer
- Roxane Laboratories, Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0300544301251
- Lot
- Lot# 660833A, Exp 08/31/18
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFurosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield,April 29, 2026
- FDAFurosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., EastJanuary 28, 2026
- FDADEXAMETHASONE ELIXIR, USP, 0.5 mg/5 mL, 8 fl.oz., Rx only, Manufactured for: QUALITEST PHARMACEUTICALS,February 1, 2017
- FDAAPD Set with Cassette 3-Prong Peritoneal Dialysis Set Indicated for use in the treatment of patients withJanuary 25, 2017
- FDAFurosemide Injection, USP, 40 mg/4mL (10 mg/mL), 4 ml Single-Dose Vial, Rx only, HOSPIRA, INC. LAKE FOREST, ILMay 15, 2013
- FDAFurosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDCMarch 6, 2013
Questions about this recall
Was Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-4297-31. recalled?
Yes. FDA published recall D-0437-2017 on February 1, 2017. Reported hazard: Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FUROSEMIDE. UPC: 0300544301251.